465.     Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003;44:570-82.

464.     Thompson JF, Uren RF, Coventry BJ, Chatterton BE. Lymphoscintigraphy. In: Balch CM, Houghton A, Jr., Sober A, Soong SJ, eds. Cutaneous Melanoma. St Louise: Quality Medical Publishing; 2003:329-52.

463.     Thompson JF, Kam PCA, Lindner P, de Wilt JH. Isolated limb infusion. In: Balch CM, Houghton A, Jr., Sober A, Soong SJ, eds. Cutaneous Melanoma. St Louis: Quality Medical Publishing; 2003:495-507.

462.     Slater M, Scolyer RA, Gidley-Baird A, Thompson JF, Barden JA. Increased expression of apoptotic markers in melanoma. Melanoma Res 2003;13:137-45.

461.     Schofield PE, Butow PN, Thompson JF, Tattersall MH, Beeney LJ, Dunn SM. Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 2003;14:48-56.

460.     Saleh FH, Crotty KA, Hersey P, Menzies SW, Rahman W. Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens. J Pathol 2003;200:383-95.

459.     Rosado B, Menzies S, Harbauer A, Pehamberger H, Wolff K, Binder M, Kittler H. Accuracy of computer diagnosis of melanoma: a quantitative meta-analysis. Arch Dermatol 2003;139:361-7; discussion 6.

458.     Reintgen D, Thompson JF, Gershenwald JE. Intraoperative mapping and sentinel node biopsy. In: Balch CM, Houghton A, Jr., Sober A, Soong SJ, eds. Cutaneous Melanoma. St Louis: Quality Medical Publishing; 2003:353-77.

457.     Orange S, Hennessy A, Horvath J, Vaughan J, Thompson J. Specific effect of acute interleukin-10 inhibition on maternal blood pressure in pregnant telemetered papio hamadryas. J Hypertens 2003;21:S203-S.

456.     McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 2003;98:1223-31.

455.     McJannett M, Butow P, Tattersall MHN, Thompson JF. Asking questions can help: development of a question prompt list for cancer patients seeing a surgeon. Eur J Cancer Prev 2003;12:397-405.

454.     Li LX, Scolyer RA, Ka VS, McKinnon JG, Shaw HM, McCarthy SW, Thompson JF. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003;27:1197-202.

453.     Li LX, Crotty KA, Scolyer RA, Thompson JF, Kril JJ, Palmer AA, McCarthy SW. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity. Melanoma Res 2003;13:581-6.

452.     Li LX, Crotty KA, Palmer AA, Kril JJ, Scolyer RA, Thompson JF, McCarthy SW. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions. Am J Dermatopathol 2003;25:190-7.

451.     Gershenwald JE, Balch CM, Soong SJ, Thompson JF. Prognostic factors and natural history. In: Balch CM, Houghton A, Jr., Sober A, Soong SJ, eds. Cutaneous Melanoma. St Louis: Quality Medical Publishing; 2003:25-54.

450.     Gershenwald JE, Balch CM, Soong SJ, Thompson JF. Prognostic factors and natural history. In: Balch CM, Houghton A, Jr., Sober A, Soong SJ, eds. Cutaneous Melanoma. St Louis: Quality Medical Publishing Inc.; 2003:25-54.

449.     Doubrovsky A, Menzies SW. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol 2003;139:1013-8.

448.     de Wilt JH, McCarthy WH, Thompson JF. Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg 2003;197:38-43.

447.     Dawson M, Doble P, Beavis A, Li LX, Soper R, Scolyer RA, Uren RF, Thompson JF. Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. Analyst 2003;128:217-9.

446.     Crotty K, McCarthy W, Quinn M, McCarthy S. Alopecia neoplastica caused by desmoplastic melanoma. Australas J Dermatol 2003;44:295-8.

445.     Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Jr., Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. New TNM melanoma staging system: Linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003;21:43-52.

444.     Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma. Cancer 2003;97:1488-98.

443.     Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D, Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Blum A, Braun R, Cabo H, Carli P, De Giorgi V, Fleming MG, Grichnik JM, Grin CM, Halpern AC, Johr R, Katz B, Kenet RO, Kittler H, Kreusch J, Malvehy J, Mazzocchetti G, Oliviero M, Ozdemir F, Peris K, Perotti R, Perusquia A, Pizzichetta MA, Puig S, Rao B, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Stanganelli I, Tanaka M, Westerhoff K, Wolf IH, Braun-Falco O, Kerl H, Nishikawa T, Wolff K, Kopf AW. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003;48:679-93.